Review



fibroblast growth factor supplemented basal medium  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    ATCC fibroblast growth factor supplemented basal medium
    In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal <t>fibroblasts</t> normal cell line control.
    Fibroblast Growth Factor Supplemented Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 472 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast growth factor supplemented basal medium/product/ATCC
    Average 97 stars, based on 472 article reviews
    fibroblast growth factor supplemented basal medium - by Bioz Stars, 2026-06
    97/100 stars

    Images

    1) Product Images from "Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells"

    Article Title: Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells

    Journal: Scientific Reports

    doi: 10.1038/s41598-020-80484-x

    In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal fibroblasts normal cell line control.
    Figure Legend Snippet: In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal fibroblasts normal cell line control.

    Techniques Used: In Vitro, Concentration Assay, Control



    Similar Products

    fibroblast growth factor supplemented basal medium  (ATCC)
    97
    ATCC fibroblast growth factor supplemented basal medium
    In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal <t>fibroblasts</t> normal cell line control.
    Fibroblast Growth Factor Supplemented Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast growth factor supplemented basal medium/product/ATCC
    Average 97 stars, based on 1 article reviews
    fibroblast growth factor supplemented basal medium - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    fibroblast basal medium supplemented with cytokines and growth factors and 2% serum (fgm-2 bulletkit)  (Lonza)
    90
    Lonza fibroblast basal medium supplemented with cytokines and growth factors and 2% serum (fgm-2 bulletkit)
    In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal <t>fibroblasts</t> normal cell line control.
    Fibroblast Basal Medium Supplemented With Cytokines And Growth Factors And 2% Serum (Fgm 2 Bulletkit), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast basal medium supplemented with cytokines and growth factors and 2% serum (fgm-2 bulletkit)/product/Lonza
    Average 90 stars, based on 1 article reviews
    fibroblast basal medium supplemented with cytokines and growth factors and 2% serum (fgm-2 bulletkit) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal fibroblasts normal cell line control.

    Journal: Scientific Reports

    Article Title: Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells

    doi: 10.1038/s41598-020-80484-x

    Figure Lengend Snippet: In vitro anti-cell proliferation analysis of MGDG extracted from Synechocystis sp. PCC 6803 (solid line) and MGDG standard (dotted line) in ( a ) BT-474 and ( b ) MDA-MB-231 cell lines. Mean percentage values are presented from six replicates (n = 6) for each drug dosage. The MGDG from the Synechocystis sp. inhibits up to 70% ( p < 0.001) and 60% ( p < 0.001) of BT-474 and MDA-MB-231 cancer cells, respectively where MGDG standard does not show any toxicity within the concentration range of 0–200 ng/ml. *** indicates the p value < 0.001 showing a statistically significant difference between % cell death in MGDG extracted from the Synechocystis sp. and MGDG standard. ( c ) MGDG extracted from the Synechocystis sp. does not show any cytotoxic side effects in human dermal fibroblasts normal cell line control.

    Article Snippet: BT-474, MDA-MB-231, and human dermal fibroblast cells (ATCC) were cultured in Hybri-care ATCC 46-X medium, RPMI 1640, and fibroblast growth factor supplemented basal medium (ATCC), respectively, supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin at 37 °C and 5% CO .

    Techniques: In Vitro, Concentration Assay, Control